K Number
K992370
Device Name
AMPLAID A724 AND A728
Manufacturer
Date Cleared
1999-09-20

(67 days)

Product Code
Regulation Number
874.1090
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Amplaid A724 and A728 are Programmable Admittance Meters which can: 1. Evaluate middle ear functions such as otitis media, glue ear, eardrum scar tissues, perform myringotomy status, ossicular chain discontinuity ear canal volume, otosclerosis, stapes fixation. 2. Perform Acoustic reflex test. 3. Determine acoustic reflex threshold 4. Perform reflex decay test. They is intended for use by a qualified/trained audiologist on both adult and pediatric subjects for measurement of acoustic impedance.
Device Description
The Amplaid A724 and A728 ADMITTANCE METERS perform plane and compensated tympanometry; Programmed and manual stimuli for ipsilateral and contralateral acoustic reflex; Automatic reflex threshold; and Decay measurements.
More Information

Not Found

No
The document describes a standard admittance meter with programmable functions for middle ear evaluation and acoustic reflex testing. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies. The focus is on traditional audiological measurements.

No
The device is described as an "Admittance Meter" used to evaluate middle ear functions and perform acoustic reflex tests. These functions are diagnostic in nature, aimed at identifying conditions rather than treating them.

Yes
The device evaluates various middle ear functions and performs acoustic reflex tests to identify conditions like otitis media, glue ear, and eardrum scar tissues, which falls under the definition of diagnostic purposes.

No

The device description explicitly states "ADMITTANCE METERS" and describes functions like performing tympanometry and acoustic reflex tests, which are inherently hardware-based measurements requiring physical interaction with the ear. The predicate device is also an "Admittance Meter," further indicating a hardware component.

Based on the provided information, the Amplaid A724 and A728 are not In Vitro Diagnostic (IVD) devices.

Here's why:

  • IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for diagnostic purposes.
  • Device Function: The Amplaid A724 and A728 are described as "Programmable Admittance Meters" that evaluate middle ear functions and perform acoustic reflex tests. They do this by measuring acoustic impedance within the ear canal and middle ear.
  • Method of Use: The device is used directly on the patient's ear (in vivo) to measure physical properties (acoustic impedance and reflexes). It does not involve the collection or analysis of specimens taken from the body.

Therefore, the Amplaid A724 and A728 fall under the category of medical devices but not specifically In Vitro Diagnostic devices. They are used for diagnostic purposes, but the diagnostic information is obtained through direct measurement of physiological responses and physical properties within the body, not through the analysis of biological samples.

N/A

Intended Use / Indications for Use

The Amplaid A724 A728 are Programmable Admittance Meters which can:

  • Evaluate middle ear functions such as otitis media, glue ear, eardrum scar tissues, perform . myringotomy status, ossicular chain discontinuity ear canal volume, otosclerosis, stapes fixation.
  • Perform Acoustic reflex test.
  • Determine acoustic reflex threshold ●
  • Perform reflex decay test. .

It is intended for use by a qualified/trained audiologist on both adult and pediatric subjects for measurement and diagnosis of various types of hearing losses.

Product codes (comma separated list FDA assigned to the subject device)

77ETY

Device Description

The Amplaid A724 and A728 ADMITTANCE METERS perform plane and compensated tympanometry; Programmed and manual stimuli for ipsilateral and contralateral acoustic reflex; Automatic reflex threshold; and Decay measurements.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

middle ear, ear canal

Indicated Patient Age Range

adult and pediatric subjects

Intended User / Care Setting

qualified/trained audiologist

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The results of bench and user testing indicates that the new device is as safe and effective as the predicate device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K903066

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 874.1090 Auditory impedance tester.

(a)
Identification. An auditory impedance tester is a device that is intended to change the air pressure in the external auditory canal and measure and graph the mobility characteristics of the tympanic membrane to evaluate the functional condition of the middle ear. The device is used to determine abnormalities in the mobility of the tympanic membrane due to stiffness, flaccidity, or the presence of fluid in the middle ear cavity. The device is also used to measure the acoustic reflex threshold from contractions of the stapedial muscle, to monitor healing of tympanic membrane grafts or stapedectomies, or to monitor followup treatment for inflammation of the middle ear.(b)
Classification. Class II (special controls). The device, when it is a tympanometer or auditory impedance tester that complies with FDA-recognized consensus standard ANSI S3.39, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 874.9.

0

K912370

SEP 2 0 1999

EXHIBIT 2 Amplifon S.p.A. Via Ripamonti, 133 20141 Milan, ITALY Tel ++39-02-57472482 Fax ++39-02-57409427 Contact: Giovanni Rollier, President

July 13, 1999

510(k) Summary of Safety and Effectiveness

    1. Identification of the Device: Proprietary-Trade Name: Amplaid A724 and A728 Classification Name: Auditory Impedance Tester 77ETY Common/Usual Name: Clinical Admittance Meter
    1. Equivalent legally marketed devices This product is similar in design and function to the Amplaid 770 Admittance Meter (K903066)
    1. Indications for Use (intended use) The Amplaid A724 A728 are Programmable Admittance Meters which can:
    • Evaluate middle ear functions such as otitis media, glue ear, eardrum scar tissues, perform . myringotomy status, ossicular chain discontinuity ear canal volume, otosclerosis, stapes fixation.
    • Perform Acoustic reflex test.
    • Determine acoustic reflex threshold ●
    • Perform reflex decay test. .

It is intended for use by a qualified/trained audiologist on both adult and pediatric subjects for measurement and diagnosis of various types of hearing losses.

    1. Description of the Device: The Amplaid A724 and A728 ADMITTANCE METERS perform plane and compensated tympanometry; Programmed and manual stimuli for ipsilateral and contralateral acoustic reflex; Automatic reflex threshold; and Decay measurements.
    1. Safety and Effectiveness, comparison to predicate device. The results of bench and user testing indicates that the new device is as safe and effective as the predicate device.

1

CharacteristicPredicate device:New device:
Amplaid 770 Per K903066Amplaid A724 -A728
Intended Use:Clinical auditory impedance
testing applications(Same)
Technical characteristics
Physical characteristics:
Computer interfaceRS232 Transmit onlyRS232 Bi-directional
DisplayBuilt-in liquid crystal(Same)
Control interfaceBuilt-in keyboard(Same)
Size/weight17.3" W x 19.3" D x 7" H,
28 lbs.19.6"w x 16"d x 8"h
18.8 lbs.
Energy Source:115/230 Vac, ± 10%, 50-60 Hz(Same)
Hardcopy Output:Built-in Thermal printer(Same)
Standards and Safety
characteristics:
Audiometric:ANSI 3.6, 1969, ISO 1975 for
contralateral, 2 cm3 cavity for
ipsilateral, IEC 61027(Same or better) Standards
updated and added:
IEC 61027 (1993); Instruments
for the measurement of aural
acoustic impedance/admittance
ANSI S3.39(1987): Specifications
for Instruments to Measure Aural
Acoustic Impedance and
Admittance (Aural Acoustic
Immittance);
IEC 60645-1: Audiometers - Part
1: Pure-tone audiometers
ANSI S3.6 (1996): Specification
for audiometers;
EN ISO 389 (1995): Acoustics -
Standard reference zero for the
calibration of pure-tone air
conduction audiometers
Electrical safety:UL-544, IEC 601Safety: EN 60601-1 Class I Type
BF (1990); EN 60601-1/A1
(1993);
EN 60601-1/A2 (1995); EN
60601-1/A13 (1996)
EMC: EN 60601-1-2 (1993)

6. Substantial Equivalence Chart

7. Conclusion

After analyzing both bench and user testing data, it is the conclusion of Amplifon S.p.A. that the Amplaid A724 and A728 are as safe and effective as the predicate device, has few technological differences, and has no new indications for use, thus rendering it substantially equivalent to the predicate device.

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol resembling a stylized eagle or bird in flight, composed of three curved lines above three wavy lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 2 0 1999

Mr. Daniel Kamm, P.E. Kamm & Associates PO Box 7007 Deerfield IL 60015 USA

Re: K992370

Trade Name: Amplaid A724 and A728 Clinical Automatic Programmable Admittance Meters Regulatory Class: II Product Code: 77 ETY Dated: July 13, 1999 Received: July 15, 1999

Dear Mr. Kamm:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations .

3

Page 2 - Mr. Daniel Kamm, P.E.

This letter will allow you to begin marketing your devices as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your devices to legally marketed predicate devices results in a classification for your devices and thus, permits your devices to proceed to the market.

If you desire specific advice for your devices on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your devices, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its tollfree number (800) 638-2041 or at (301) 443-6597.

Sincerely yours,

Alvarez Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

j) Indications for Use

510(k) Number K9923 70

Device Name: Amplaid A724 and A728 Clinical Automatic Programmable Admittance Meters

Indications for Use: The Amplaid A724 and A728 are Programmable Admittance Meters which can

    1. Evaluate middle ear functions such as otitis media, glue ear, eardrum scar tissues, perform myringotomy status, ossicular chain discontinuity ear canal volume, otosclerosis, stapes fixation.
    1. Perform Acoustic reflex test.
    1. Determine acoustic reflex threshold
    1. Perform reflex decay test.

They is intended for use by a qualified/trained audiologist on both adult and pediatric subjects for measurement of acoustic impedance.

Concurrence of CDRH, Office of Device Evaluation (ODE)

Ray J. Lankester

OR

Prescription Use /

Over the Counter Use (Per 21 CFR 801.109)

. "